Reference 22 - Gadolinium deposition in bone tissues after contrast-enhanced

NonrulemakingSupporting & Related MaterialFDA-2026-P-6737-0024
🔔 Subscribe
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 15, 2026
Agency
Food and Drug Administration (FDA)
© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets